Clonidine in patients undergoing noncardiac surgery.

BACKGROUND Marked activation of the sympathetic nervous system occurs during and after noncardiac surgery. Low-dose clonidine, which blunts central sympathetic outflow, may prevent perioperative myocardial infarction and death without inducing hemodynamic instability. METHODS We performed a blinded, randomized trial with a 2-by-2 factorial design to allow separate evaluation of low-dose clonidine versus placebo and low-dose aspirin versus placebo in patients with, or at risk for, atherosclerotic disease who were undergoing noncardiac surgery. A total of 10,010 patients at 135 centers in 23 countries were enrolled. For the comparison of clonidine with placebo, patients were randomly assigned to receive clonidine (0.2 mg per day) or placebo just before surgery, with the study drug continued until 72 hours after surgery. The primary outcome was a composite of death or nonfatal myocardial infarction at 30 days. RESULTS Clonidine, as compared with placebo, did not reduce the number of primary-outcome events (367 and 339, respectively; hazard ratio with clonidine, 1.08; 95% confidence interval [CI], 0.93 to 1.26; P=0.29). Myocardial infarction occurred in 329 patients (6.6%) assigned to clonidine and in 295 patients (5.9%) assigned to placebo (hazard ratio, 1.11; 95% CI, 0.95 to 1.30; P=0.18). Significantly more patients in the clonidine group than in the placebo group had clinically important hypotension (2385 patients [47.6%] vs. 1854 patients [37.1%]; hazard ratio 1.32; 95% CI, 1.24 to 1.40; P<0.001). Clonidine, as compared with placebo, was associated with an increased rate of nonfatal cardiac arrest (0.3% [16 patients] vs. 0.1% [5 patients]; hazard ratio, 3.20; 95% CI, 1.17 to 8.73; P=0.02). CONCLUSIONS Administration of low-dose clonidine in patients undergoing noncardiac surgery did not reduce the rate of the composite outcome of death or nonfatal myocardial infarction; it did, however, increase the risk of clinically important hypotension and nonfatal cardiac arrest. (Funded by the Canadian Institutes of Health Research and others; POISE-2 ClinicalTrials.gov number, NCT01082874.).

[1]  P. Devereaux.  Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 × 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. , 2014, American heart journal.

[2]  G. Guyatt,et al.  Aspirin in patients undergoing noncardiac surgery. , 2014, The New England journal of medicine.

[3]  Denis Xavier,et al.  Characteristics and Short-Term Prognosis of Perioperative Myocardial Infarction in Patients Undergoing Noncardiac Surgery , 2011, Annals of Internal Medicine.

[4]  J. Eikelboom,et al.  Major Vascular Complications in Patients Undergoing Non‐Cardiac Surgery: Magnitude of the Problem, Risk Prediction, Surveillance, and Prevention , 2010 .

[5]  D. Hu,et al.  Evidence-Based Cardiology , 2010 .

[6]  Joseph S. Alpert,et al.  Perioperative Myocardial Infarction , 2009, Circulation.

[7]  Denis Xavier,et al.  Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial , 2008, The Lancet.

[8]  S. McCluskey,et al.  Does Tight Heart Rate Control Improve Beta-Blocker Efficacy? An Updated Analysis of the Noncardiac Surgical Randomized Trials , 2008, Anesthesia and analgesia.

[9]  T. Hachenberg,et al.  Clonidine Decreases Stress Response in Patients Undergoing Carotid Endarterectomy Under Regional Anesthesia: A Prospective, Randomized, Double-Blinded, Placebo-Controlled Study , 2006, Anesthesia and analgesia.

[10]  Chi-Yuan Li,et al.  The Effect of Epidural Clonidine on Perioperative Cytokine Response, Postoperative Pain, and Bowel Function in Patients Undergoing Colorectal Surgery , 2004, Anesthesia and analgesia.

[11]  Arthur W Wallace,et al.  Effect of Clonidine on Cardiovascular Morbidity and Mortality after Noncardiac Surgery , 2004, Anesthesiology.

[12]  D. Wijeysundera,et al.  Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. , 2003, The American journal of medicine.

[13]  I. Kamae,et al.  Efficacy of Clonidine for Prevention of Perioperative Myocardial Ischemia: A Critical Appraisal and Meta-analysis of the Literature , 2002, Anesthesiology.

[14]  P. Kranke,et al.  Pharmacological Treatment of Postoperative Shivering: A Quantitative Systematic Review of Randomized Controlled Trials , 2002, Anesthesia and analgesia.

[15]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[16]  Gries,et al.  Perioperative catecholamine changes in cardiac risk patients , 1999, European journal of clinical investigation.

[17]  B. Mainzer,et al.  Small, Oral Dose of Clonidine Reduces the Incidence of Intraoperative Myocardial Ischemia in Patients Having Vascular Surgery , 1996, Anesthesiology.

[18]  J. Viale,et al.  Clonidine for Major Vascular Surgery in Hypertensive Patients: A Double-Blind, Controlled, Randomized Study , 1996, Anesthesia and analgesia.

[19]  R. Thisted,et al.  Premedication with Oral and Transdermal Clonidine Provides Safe and Efficacious Postoperative Sympatholysis , 1994, Anesthesia and analgesia.

[20]  D. A. Cook,et al.  Hormonal Responses to Graded Surgical Stress , 1988 .

[21]  M. S. Langley,et al.  Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. , 1988, Drugs.

[22]  J. Norton,et al.  Responses of the hypothalamic-pituitary-adrenal and renin-angiotensin axes and the sympathetic system during controlled surgical and anesthetic stress. , 1987, The Journal of clinical endocrinology and metabolism.